Daicel Corporation Stocks

¥ 1218.5Last Updated 27.04.2026

Issuer Rating

7/7
Performance

Strong

Risk

Low

Recommendation

Buy

Market Cap

¥ 1.93B

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
¥ 1218.5
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Daicel Corporation manufactures and sells cellulosic derivatives, organic chemicals, plastics, pyrotechnic devices, and other products in Japan, Asia, North America, and Europe. It operates through Medical/Healthcare, Smart, Safety, Materials, Engineering Plastics, and Others segments. The company offers 1,3-Butylene glycol, polyglycerin, and thickener for cosmetics; natural health food materials and supplements; and chiral and achiral columns, chiral reagents, bio reagents, and DNA and RNA-based probes, as well as analytical/purification/synthesis/formulation services, and analytical tools services for pharmaceuticals. It also provides triacetylcellulose and films for display market; solvent for electronic materials, polymers for resist, and semiconductor process cleaning agents; and optical parts and lens units, silver nanoparticle inks, and organic semiconductor devices for visualization technology. In addition, the company offers inflators for air bags and pyro-fuse for automotive market, as well as safety device for non-mobility products; acetic acid and derivatives, cellulose acetate, acetate tow, and other raw materials for resins and inks, and solvents for paints; and cycloaliphatic epoxies, caprolactone, ketene derivatives, alkylamines, and other raw materials for electrical materials and coatings. Further, it provides a range of plastics, such as engineering plastics, plastic compound products, functional sheets, formed trays, and packaging films for engineering plastics segment. Additionally, the company manufactures and distributes water treatment systems and diffusers for a range of industrial applications. Its products are used in transportation, electronics, medical care, personal care, everyday life, and environment and energy applications. The company was formerly known as Daicel Chemical Industries, Ltd. and changed its name to Daicel Corporation in October 2011. Daicel Corporation was incorporated in 1919 and headquartered in Osaka, Japan.

Company Valuation

Greatly undervalued
7/7

Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBITD

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Neutral
4/7

The average target price of 4202.T is 1496 and suggests 23% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks